The African Initiative for Bioinformatics Online Training in Neurodegenerative Diseases (AI-BOND): Investing in the next generat
Authors:
Journal: Alzheimer's & dementia (New York, N. Y.)
Publication Type: Journal Article
Date: 2024
DOI: PMC11694528
ID: 39748840
Abstract
Neurodegenerative disorders, including Alzheimer's disease and AD-related dementias (AD/ADRD), pose significant challenges to health care systems globally, particularly in Africa. With the advances in medical technology and research capabilities, especially in next-generation sequencing and imaging, vast amounts of data have been generated from AD/ADRD research. Given that the greatest increase in AD/ADRD prevalence is expected to occur in Africa, it is critical to establish comprehensive bioinformatics training programs to help African scientists leverage existing data and collect additional information to untangle AD/ADRD heterogeneity in African populations. The South Texas Alzheimer's Disease Research Center, with efforts from the National Institutes of Health and the Global Brain Health Institute, has partnered with the Brain Research Africa Initiative to develop the frican nitiative on ioinformatics nline Training in eurodegenerative isease (). AI-BOND is a comprehensive and accessible training program, the aim of which is to advance biostatistics and bioinformatics expertise in Africa in studying neurodegenerative diseases. This expertise is essential to enable African scientists to utilize the extensive AD/ADRD data and enhance the continent's ability to contribute to global research efforts in this field. The training addresses the gap in analyzing neurodegenerative disease data by providing skills and knowledge in genetic epidemiology, biostatistics, and bioinformatics to African students and researchers. This innovative online training program will last 6 months and provide training in skill sets R, SAS, and Python programing, genome-wide association studies, genomics, transcriptomics, proteomics, metabolomics, microbiome analysis, and advanced statistical methods. Additional training will include study design and manuscript and grant writing. The first cohort of the AI-BOND program will graduate in June 2024. The AI-BOND program is expected to build research computational capacities in Africa that will improve the ability of graduates to conduct and utilize large-scale studies, with the goal of curbing the growing incidence of neurodegenerative diseases in Africa.
Reference List
- Aranda MP, Kremer IN, Hinton L, et al. Impact of dementia: health disparities, population trends, care interventions, and economic costs. J Am Geriatr Soc. 2021;69(7):1774‐1783. doi:10.1111/jgs.17345|||Andrade‐Guerrero J, Santiago‐Balmaseda A, Jeronimo‐Aguilar P, et al. Alzheimer's disease: an updated overview of its genetics. Int J Mol Sci. 2023;24(4):3754. doi:10.3390/ijms24043754|||Maestre G, Carrillo M, Kalaria R, et al. The Nairobi Declaration‐reducing the burden of dementia in low‐ and middle‐income countries (LMICs): declaration of the 2022 symposium on dementia and brain aging in LMICs. Alzheimers Dement. 2023. doi:10.1002/alz.13025|||Akinyemi RO, Yaria J, Ojagbemi A, et al. Dementia in Africa: current evidence, knowledge gaps, and future directions. Alzheimers Dement. 2022;18(4):790‐809. doi:10.1002/alz.12432|||
Alzheimer's Disease International
. et al. Dementia in sub‐Saharan Africa: Challenges and opportunities. Alzheimer's Disease International; 2017. https://www.alzint.org/u/dementia-sub-saharan-africa.pdf
|||Ayele BA, Ali S, Anbessie M, et al. The need for a tailored national dementia plan in Ethiopia: a call for action. Front Neurol. 2023;14:1126531. doi:10.3389/fneur.2023.1126531|||Stephen R, Barbera M, Peters R, et al. Development of the first WHO guidelines for risk reduction of cognitive decline and dementia: lessons learned and future directions. Front Neurol. 2021;12:763573. doi:10.3389/fneur.2021.763573|||GBD 2019 Dementia Forecasting Collaborators . Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019. Lancet Public Health. 2022;7(2):e105‐e125. doi:10.1016/S2468-2667(21)00249-8|||Sirugo G, Williams SM, Tishkoff SA. The missing diversity in human genetic studies. Cell. 2019;177(1):1080. doi:10.1016/j.cell.2019.02.048|||Njamnshi AK, Ngarka L, Njamnshi WY; BRAIN‐SCAN Congress 1.5 Scientific Committee and Organising Secretariat , et al. The Brain Research Africa Initiative (BRAIN). Lancet Neurol. 2023;22(6):467‐468. doi:10.1016/S1474-4422(23)00164-3|||Kanzi AM, San JE, Chimukangara B, et al. Next generation sequencing and bioinformatics analysis of family genetic inheritance. Front Genet. 2020;11:544162. doi:10.3389/fgene.2020.544162|||Cahill S. WHO's global action plan on the public health response to dementia: some challenges and opportunities. Aging Ment Health. 2020;24(2):197‐199. doi:10.1080/13607863.2018.1544213|||Karikari TK, Aleksic J. Neurogenomics: An opportunity to integrate neuroscience, genomics and bioinformatics research in Africa. Appl Transl Genom. 2015;5:3‐10. doi:10.1016/j.atg.2015.06.004